Biogen Inc.BIIBNASDAQ
LOADING
|||
Operating Income Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
4.37%
↓ 57% below average
Average (39q)
10.09%
Historical baseline
Range
High:394.59%
Low:-130.43%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 4.37% |
| Q2 2025 | -19.72% |
| Q1 2025 | 43.93% |
| Q4 2024 | -11.82% |
| Q3 2024 | 57.49% |
| Q2 2024 | -46.91% |
| Q1 2024 | 34.74% |
| Q4 2023 | 59.73% |
| Q3 2023 | -53.49% |
| Q2 2023 | 20.07% |
| Q1 2023 | 2.88% |
| Q4 2022 | -35.83% |
| Q3 2022 | -7.09% |
| Q2 2022 | 78.57% |
| Q1 2022 | 3.45% |
| Q4 2021 | -36.61% |
| Q3 2021 | 69.84% |
| Q2 2021 | -51.66% |
| Q1 2021 | 394.59% |
| Q4 2020 | -130.43% |
| Q3 2020 | -44.98% |
| Q2 2020 | 8.49% |
| Q1 2020 | 2.37% |
| Q4 2019 | -1.58% |
| Q3 2019 | -7.65% |
| Q2 2019 | 30.16% |
| Q1 2019 | 4.13% |
| Q4 2018 | -14.99% |
| Q3 2018 | 39.93% |
| Q2 2018 | -20.95% |
| Q1 2018 | 4.67% |
| Q4 2017 | -11.35% |
| Q3 2017 | 37.71% |
| Q2 2017 | 17.21% |
| Q1 2017 | 15.63% |
| Q4 2016 | -37.82% |
| Q3 2016 | -2.41% |
| Q2 2016 | 5.96% |
| Q1 2016 | 17.99% |
| Q4 2015 | -14.84% |